Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real‐World Clinical Outcomes and Lipid Profile Evaluation
Australasian Journal of Dermatology · 2025
DOI: 10.1111/ajd.14592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2025. Verfasst von R Cascio Ingurgio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Lipids, Biological Therapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with systemic implications. While biologic therapies have demonstrated efficacy in controlling cutaneous lesions, their systemic effects, particularly on lipid metabolism as a marker of systemic inflammation, are less understood.
Objectives
To evaluate the impact of biologic therapy on clinical severity and lipid profiles in HS patients in a real‐world setting, comparing outcomes between Early and Late Responders at Week 24 ± 4.
Methods
Twenty‐four patients with moderate‐to‐severe HS on biologic therapy were monitored prospectively at Baseline, Week 24 ± 4, Week 52 and Week 104. Clinical parameters (IHS4, A/N, HS‐IGA) and lipid profiles (cholesterol, triglycerides) were analysed. Patients were categorised as Early (IHS4 ≤ 10) or Late Responders (IHS4 ≥ 11) at Week 24 ± 4. Statistical analysis included t ‐tests; significance was set at p < 0.05.
Results
Early Responders showed significant clinical improvement and reductions in lipid levels, suggesting a systemic anti‐inflammatory effect of therapy. However, lipid reductions did not reach statistical significance ( p > 0.05); likely due to the small sample size. Late Responders demonstrated less pronounced changes.
Conclusions
Biologic therapy appears to improve both clinical and systemic inflammatory markers in HS, highlighting the value of metabolic monitoring in routine care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
- Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia.
- Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
ORCID-Profile: R Cascio Ingurgio, A Alfano, D F Murrell
Zitieren
APA
Cascio Ingurgio, R., Alfano, A., Matteodo, E., Stark, M., Valenti, M., Narcisi, A., Costanzo, A., & Murrell, D. F. (2025). Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real‐World Clinical Outcomes and Lipid Profile Evaluation. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14592
Vancouver
Cascio Ingurgio R, Alfano A, Matteodo E, Stark M, Valenti M, Narcisi A, et al. Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real‐World Clinical Outcomes and Lipid Profile Evaluation. Australasian Journal of Dermatology. 2025. doi:10.1111/ajd.14592
BibTeX
@article{CascioIngurgio2025,
author = {Cascio Ingurgio, R and Alfano, A and Matteodo, E and Stark, M and Valenti, M and Narcisi, A and Costanzo, A and Murrell, D F},
title = {Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real‐World Clinical Outcomes and Lipid Profile Evaluation},
journal = {Australasian Journal of Dermatology},
year = {2025},
doi = {10.1111/ajd.14592}
}
EUVIMED